Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) EBT Margin (2021 - 2025)

PAVmed has reported EBT Margin over the past 5 years, most recently at 3403.7% for Q4 2025.

  • For Q4 2025, EBT Margin fell 1482370.0% year-over-year to 3403.7%; the TTM value through Dec 2025 reached 2469.0%, down 83869.0%, while the annual FY2025 figure was 2469.0%, 341815.0% down from the prior year.
  • EBT Margin for Q4 2025 was 3403.7% at PAVmed, up from 120220.0% in the prior quarter.
  • Over five years, EBT Margin peaked at 232787.5% in Q1 2025 and troughed at 205400.0% in Q2 2025.
  • A 5-year average of 12090.35% and a median of 5770.19% in 2023 define the central range for EBT Margin.
  • On a YoY basis, EBT Margin climbed as much as 23462037bps in 2025 and fell as far as -20387661bps in 2025.
  • Year by year, EBT Margin stood at 6559.67% in 2021, then plummeted by -234bps to 21939.29% in 2022, then surged by 92bps to 1659.49% in 2023, then soared by 788bps to 11420.0% in 2024, then tumbled by -130bps to 3403.7% in 2025.
  • Business Quant data shows EBT Margin for PAVM at 3403.7% in Q4 2025, 120220.0% in Q3 2025, and 205400.0% in Q2 2025.